Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinmaikang capsule for stable exertional angina
CTR20130721Phase 3Active
- Sponsor
- First Affiliated Hospital of Guangxi University of Chinese Medicine
- Start
- Oct 2013
- Countries
- 1
01
Overview
A Phase 3 trial of Xinmaikang in coronary arteriosclerosis, angina pectoris, sponsored by First Affiliated Hospital of Guangxi University of Chinese Medicine. Started Oct 2013; status: active.
02
Drugs
Xinmaikang
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20130721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130721.